正常和恶性血液形成的EVI1介导编程
Susanne Lux1, Michael D Milsom1,2,3
1Division of Experimental Hematology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
HemaSphere
|October 9, 2023
概括
生态热带病毒整合部位1 (EVI1) 是一种在癌症,特别是髓性白血病中过度表达的瘤原因子. 准EVI1可能会改善高EVI1表达的患者的治疗结果.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 基因调节 基因调节
背景情况:
- 由MECOM位点编码的Ecotropic病毒整合位点1 (EVI1) 是一种瘤性转录因子.
- EVI1在正常发育中发挥关键作用,包括血液形成和神经系统发育,具有定义的空间和时间表达模式.
- EVI1的功能既是转录激活器又是抑制器,通过与其他因素的相互作用和染色质重塑,影响细胞增殖,分化和存活.
研究的目的:
- 研究EVI1在癌症中的作用,特别是其在各种恶性瘤中的过度表达.
- 了解EVI1过度表达的临床影响,特别是其与预后不佳和治疗抵抗的关联.
- 探索EVI1作为"EVI1高"造血性恶性瘤的高风险患者的潜在治疗标.
主要方法:
- 在正常发育和癌症中分析EVI1表达模式.
- 研究EVI1的分子机制,包括其与转录因子和染色质重塑的相互作用.
- 在癌症患者中,EVI1过度表达与临床结果和治疗反应的相关性.
主要成果:
- 在各种癌症中,EVI1过度表达,包括卵巢,胰腺和骨髓性白血病.
- 过度表达EVI1始终与不良的临床结果和对治疗的耐药性有关.
- 在组织发育过程中,EVI1表现出严格的空间和时间表达.
结论:
- EVI1是一种重要的致癌因子,在癌症的发展和进展中起着关键作用.
- 向EVI1是一个有希望的策略,可以改善"高EVI1"癌症的治疗结果,特别是血液恶性瘤.
- 进一步研究EVI1的功能是有必要的,以开发有效的治疗干预措施.
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
01:21Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
01:20Overview of Hematopoiesis
4.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.1K
01:28Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K